Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q3 FY21 results · Oct–Dec 2020
Abbott India reported revenue from operations of ₹1,095.37 crore (up 1.6% from Q3 FY20) and net profit of ₹177.14 crore (down 5.1% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a standalone basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,095.37 | 1,078.25 | +1.6% | 1,054.85 | +3.8% |
| Other income | 15.01 | 27.76 | −45.9% | 22.06 | −32.0% |
| Total income | 1,110.38 | 1,106.01 | +0.4% | 1,076.91 | +3.1% |
| Profit before tax | 237.88 | 250.55 | −5.1% | 243.69 | −2.4% |
| Net profit for the period | 177.14 | 186.69 | −5.1% | 180.73 | −2.0% |
| EPS, basic (₹) | 83.36 | 87.85 | −5.1% | 85.05 | −2.0% |
| Net margin (%) | 16.2 | 17.3 | 17.1 |
Standalone
- Filed with BSE
- 09 Feb 2021, 15:59 IST
- Board meeting
- 09 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE